Vectus Biosystems Limited (ASX:VBS) is developing a treatment for fibrosis and high blood pressure, which includes the treatment for three of the largest diseases in the fibrotic market, namely heart, kidney and liver diseases. Vectus successfully completed its Initial Public Offering (IPO) on the A...See more
Headquarter Australia |
Countries of operation Australia |
Funding status Publicly listed on stock exchange |
Company type MNC / Large Enterprise |
Senior Research Scientist
Research Scientist